Myovant Sciences, Pfizer gain FDA approval for new indication of MyfembreeMyfembree is a once-daily treatment for the management of moderate to severe pain associated with endometriosis. Walgreens rolls out 2022-2023 flu shotsA $5 Walgreens Cash reward is being offered to individuals who receive any vaccination at Walgreens, and a $10 Walgreens Cash reward will be offered in September. Glenmark obtains FDA OK for generic Taytulla Generic Taytulla is used for the prevention of pregnancy. Walgreens taps Min Cho as chief format concepts and design officer Cho will focus on innovative store design and architecture. Walgreens offering new round of pay hikes, bonuses, well-being initiatives Walgreens is hiking pharmacist base pay rate ranges and extending premium pay for pharmacists electing to work additional shifts. Strides receives FDA nod for generic Neoral Generic Neoral is used as an immunosuppressant medication. CVS Health investing $18.9M in affordable housing in Columbus, Ohio CVS Health's new investment brings the company’s total supportive housing investment in Columbus to $44.6 million. FDA gives Daiichi Sankyo approval for Enhertu Enhertu is the first approved therapy targeted to patients with the HER2-low breast cancer subtype, which is a newly defined subset of HER2-negative breast cancer. Report: Digestive health products market to reach $89.9B by 2030 The rising geriatric population, increasing healthcare costs and changing lifestyle are primary factors that have contributed towards market growth. Cardinal Health announces leadership changes aside Q4, full-year results Cardinal Health’s revenue increased 11% to $47.1 billion in the fourth quarter and fiscal year 2022 revenues increased 12% to $181.4 billion. First Previous 532 533 534 535 536 Next Last
